On October 30, MacroGenics, Inc. (NASDAQ:MGNX) announced that it will present pre-clinical data on MGD006 in a poster session at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Barcelona, Spain on November 18-21, 2014. MacroGenics, Inc. (NASDAQ:MGNX) belongs to Healthcare sector. Its net profit margin is -26.20% and weekly performance is -1.92%. On last trading day company shares ended up $19.88. MacroGenics, Inc. (NASDAQ:MGNX) distance from 50-day simple moving average (SMA50) is -2.89%. On Nov 03, Hemispherx Biopharma, Inc. (NYSEMKT:HEB), has been informed by USAMRIID scientists that they have in-vitro data indicating that Alferon®, the only multi-species, natural alpha interferon (IFN) commercially approved in the U.S., successfully protected human cells against the Ebola virus. Low concentrations of Ampligen®, an experimental double-stranded (ds) RNA therapeutic, also successfully protected human cells against the Ebola virus USAMRIID plans to continue to collect data and to initiate in-vitro synergy studies using Alferon® and Ampligen®. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) shares remains unchanged in last trading session and ended the day at $0.31. HEB return on assets is -47.70%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) quarterly performance is 10.71%. On Oct 26, Blood products and vaccine maker CSL Ltd. (CSL.AU) has agreed to buy Novartis AG (NYSE:NVS) influenza-vaccine business for US$275 million, as the Australia-based company continues its global expansion. On 05 November, Novartis AG (NYSE:NVS) shares increased 0.76% and was closed at $92.63. NVS EPS growth in last 5 year was 0.80%. Novartis AG (NYSE:NVS) year to date (YTD) performance is 19.12%. ITC Holdings Corp. (NYSE:ITC) was downgraded by equities research analysts at Deutsche Bank from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. They currently have a $38.00 target price on the stock. Deutsche Bank’s price target points to a potential downside of 4.21% from the company’s current price.ITC Holdings Corp. (NYSE:ITC) ended the last trading day at $40.21. Company weekly volatility is calculated as 1.78% and price to cash ratio as 695.81. ITC Holdings Corp. (NYSE:ITC) showed a weekly performance of 4.06%. Third Quarter 2014 Results Resource America, Inc. (NASDAQ: REXI) reported adjusted net income attributable to common shareholders, a non-GAAP measure, of $2.8 million, or $0.13 per common share-diluted, and $9.7 million, or $0.44 per common share-diluted, for the three and nine months ended September 30, 2014 as compared to adjusted net income attributable to common shareholders of $4.3 million, or $0.20 per common share-diluted, and $7.2 million, or $0.33 per common share-diluted, for the three and nine months ended September 30, 2013, respectively. Resource America, Inc. (NASDAQ:REXI) shares increased 1.10% in last trading session and ended the day at $9.19. REXI return on assets is 0.30%. Resource America, Inc. (NASDAQ:REXI) quarterly performance is -0.11%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
